{
  "$schema": "https://pointcast.xyz/for-agents",
  "generatedAt": "2026-05-16T17:11:48.496Z",
  "name": "Nouns Cola Fundable Brief",
  "status": "published strategy brief",
  "human": "https://pointcast.xyz/nouns-cola-fundraise",
  "archiveBlock": {
    "id": "0392",
    "url": "https://pointcast.xyz/b/0392",
    "jsonUrl": "https://pointcast.xyz/b/0392.json"
  },
  "thesis": "Classic cola first, adaptogen lane second.",
  "recommendation": {
    "launchSku": "classic cola pilot",
    "rdSku": "adaptogen line extension after formulation, safety, and labeling review",
    "reason": "Makes the first raise easier to understand and lowers formulation and compliance risk."
  },
  "adaptogenEvidence": [
    {
      "ingredient": "ashwagandha",
      "target": "stress / sleep support",
      "evidence": "best-supported adaptogen lane",
      "caution": "thyroid, liver, sedatives, pregnancy, interaction risk"
    },
    {
      "ingredient": "rhodiola rosea",
      "target": "fatigue / focus",
      "evidence": "mixed",
      "caution": "insomnia, stimulation, medication interactions"
    },
    {
      "ingredient": "Panax ginseng",
      "target": "vitality / fatigue",
      "evidence": "modest",
      "caution": "blood sugar, sleep, clotting, autoimmune concerns"
    }
  ],
  "capitalPlan": {
    "targetUsd": 120000,
    "uses": [
      {
        "use": "Classic cola pilot",
        "amountUsd": 96000
      },
      {
        "use": "Adaptogen R&D reserve",
        "amountUsd": 12000
      },
      {
        "use": "PointCast launch media",
        "amountUsd": 12000
      }
    ]
  },
  "rules": [
    "Raise against the pilot everyone can understand.",
    "Keep adaptogen claims conservative until counsel and labeling review are complete.",
    "Use PointCast to show gates, proofs, and receipts in public.",
    "Do not frame preorders or sponsor crates as financial upside."
  ],
  "links": {
    "board": "https://pointcast.xyz/nouns-cola",
    "boardJson": "https://pointcast.xyz/nouns-cola.json",
    "sprint": "https://pointcast.xyz/next-sprint",
    "listeningRoom": "https://pointcast.xyz/listening-room"
  },
  "caveats": [
    "Strategy and planning only.",
    "Not an offer, investment product, or promise of return.",
    "Food, supplement, labeling, and marketing claims require qualified review before sale."
  ]
}